Glia Pharm

Developer of treatments for neurological and psychiatric disorders

placeLausanne, Vaud, Switzerland calendar_todayFounded 2016 groups9 employees language gliapharm.com

Social engagement

Social engagement: 2K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Alzheimer's Drug Discovery, Fongit.

Investor typeCountShare
Venture capital117%
Accelerator & incubator233%
Other / undisclosed350%

Recent activity

16 Sep 2025
Event
Symposium
8 Sep 2025
Event
gliapharm
26 Aug 2025
Event
1st Puccini Foundation Symposium on ALS
Coming soon